Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Change in Acquisitions & Divestments (2019 - 2025)

Historic Change in Acquisitions & Divestments for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $22.8 million.

  • Korro Bio's Change in Acquisitions & Divestments rose 6285.0% to $22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.6 million, marking a year-over-year increase of 49000.0%. This contributed to the annual value of $40.9 million for FY2024, which is 11526.32% up from last year.
  • As of Q3 2025, Korro Bio's Change in Acquisitions & Divestments stood at $22.8 million, which was up 6285.0% from $1000.0 recorded in Q2 2025.
  • In the past 5 years, Korro Bio's Change in Acquisitions & Divestments registered a high of $32.9 million during Q1 2025, and its lowest value of $1000.0 during Q2 2025.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $14.0 million (2024), whereas its average is $13.2 million.
  • In the last 5 years, Korro Bio's Change in Acquisitions & Divestments surged by 9447500.0% in 2021 and then crashed by 9986.25% in 2022.
  • Quarter analysis of 5 years shows Korro Bio's Change in Acquisitions & Divestments stood at $11.6 million in 2021, then crashed by 99.86% to $16000.0 in 2022, then soared by 6150.0% to $1.0 million in 2023, then soared by 2590.0% to $26.9 million in 2024, then fell by 15.25% to $22.8 million in 2025.
  • Its last three reported values are $22.8 million in Q3 2025, $1000.0 for Q2 2025, and $32.9 million during Q1 2025.